Factors associated with potentially inappropriate phosphodiesterase-5 inhibitor use for pulmonary hypertension in the United States, 2006 to 2015
Circulation: Cardiovascular Quality and Outcomes | May 22, 2020
Factors associated with potentially inappropriate phosphodiesterase-5 inhibitor use for pulmonary hypertension in the United States, 2006 to 2015
Circulation: Cardiovascular Quality and Outcomes | May 20, 2020